Abstract
Despite many recent advances in the management of gliomas, such as aggressive surgical resection, chemoradiotherapy, antiangiogenic therapy, and molecular targeted therapy, the survival of patients with high-grade neoplasms remains dismal. Gene therapy and oncolytic virotherapy have emerged as highly promising strategies for treatment of malignant brain tumors due to recent progress in understanding of the underlying cancer biology as well as improved techniques for genetic modification of potential therapeutics.
Original language | English (US) |
---|---|
Pages (from-to) | 112-123 |
Number of pages | 12 |
Journal | Progress in Neurological Surgery |
Volume | 32 |
DOIs | |
State | Published - 2018 |
ASJC Scopus subject areas
- Surgery
- Clinical Neurology